Open AccessDistal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1–Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings
Author(s) -
Alyssa Vecchio,
Christina M. Marra,
Jeffrey T. Schouten,
Hongyu Jiang,
Johnstone Kumwenda,
Khuanchai Supparatpinyo,
James Hakim,
Ned Sacktor,
Thomas Campbell,
Srikanth Tripathy,
Nagalingeswaran Kumarasamy,
Alberto La Rosa,
Breno Santos,
Marcus Tolentino Silva,
Cecilia Kanyama,
Cindy Firnhaber,
Mina C. Hosseinipour,
Rosie Mngqibisa,
Colin D. Hall,
Paola Cinque,
Kevin Robertson
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz745
Subject(s) - cart , medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , regimen , peripheral neuropathy , gastroenterology , viral load , immunology , endocrinology , diabetes mellitus , mechanical engineering , engineering
Distal sensory peripheral neuropathy (DSPN) is a complication of human immunodeficiency virus (HIV). We estimate DSPN prevalence in 7 resource-limited settings (RLSs) for combination antiretroviral therapy (cART)-naive people living with HIV (PLWH) compared with matched participants not living with HIV and in PLWH virally suppressed on 1 of 3 cART regimens.